Results 141 to 150 of about 36,202 (238)

Exploring Pain Researcher and Clinician Perceptions of Complementary, Alternative, and Integrative Medicine: A Large‐Scale, International Cross‐Sectional Survey

open access: yesPain Practice, Volume 26, Issue 4, April 2026.
ABSTRACT Introduction Complementary, alternative, and integrative medicine (CAIM) has gained popularity among patients experiencing pain, used alongside conventional medical treatments. This study aimed to explore the perceptions of pain clinicians and researchers on CAIM interventions.
Jeremy Y. Ng   +2 more
wiley   +1 more source

Wittgenstein, normativity and the ‘space of reasons’

open access: yesPhilosophical Investigations, Volume 49, Issue 2, Page 195-211, April 2026.
Abstract Wittgenstein's naturalism illuminates our ordinary normative practices of giving and asking for reasons and also related ‘philosophical’ conceptions of knowledge inspired by, for example, Sellars's image of the ‘space of reasons’. Some propose that the relevant naturalism motivates scepticism about the ‘space of reasons’ insofar as it ...
Benedict Smith
wiley   +1 more source

Cingulotomy for Intractable Pain: A Systematic Review of an Underutilized Procedure. [PDF]

open access: yesCureus
McBenedict B   +13 more
europepmc   +1 more source

Intractable Functional Abdominal Pain [PDF]

open access: yesJournal of the Royal Society of Medicine, 1987
openaire   +2 more sources

Nationwide Survey of Atopic Myelitis and Plexin D1‐Immunoglobulin G‐Related Pain

open access: yesAnnals of Clinical and Translational Neurology, Volume 13, Issue 3, Page 593-606, March 2026.
ABSTRACT Objective To elucidate the features of plexin D1‐immunoglobulin (Ig)G‐associated neuropathic pain and its relationship to atopic myelitis (AM) in a nationwide Japanese survey. Methods A preliminary survey questionnaire was sent to 1574 selected departments (neurology and pediatrics/pediatric neurology) to explore the numbers of AM and plexin ...
Jun‐ichi Kira   +10 more
wiley   +1 more source

Cytokine‐Engineered Chimeric Antigen Receptor‐T Cell Therapy: How to Balance the Efficacy and Toxicity

open access: yesAdvanced Science, Volume 13, Issue 14, 9 March 2026.
Cytokine‐engineered CAR‐T cells represent a promising immunotherapy against malignancies due to direct tumor killing and potent immunity response. However, significant toxicities, including CRS and ICANS, have restricted clinical applications. How to keep the risk‐benefit balance of the advanced therapy is of great importance for maximizing the benefit
Xinru Zhang   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy